Zahra Masoud

Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.

4CMedB, a new multi-antigen vaccine designed to control group B meningococcal disease, had no effect on carriage of disease-causing meningococci in adolescents.

Results of this study showed that patients with CSF leak associated bacterial meningitis have a relatively high recurrence rate, despite attempts to repair the leak or vaccination.

The tryptophan-kynurenine-NAD+ (TK) pathway may provide accurate cerebrospinal fluid biomarkers.